
    
      This study is a randomized double-blind placebo-controlled clinical trial.

      Primary outcome: propofol doses required to achieve adequate sedation.

      Population: children submitting to upper digestive endoscopy, weight > 30 kg and age between
      8 and 18 years.

      Exclusion criteria: neurological disorders, psychiatric disorders, specific contra-indication
      to either lidocaine or propofol.

      Estimated sample: 160 patients. Placebo: tannic acid 0.5%
    
  